Teladoc Health
TDOC | NYSE
$8.70
-$0.10 (-1.14%)
At close: Nov 16, 2026, 4:00 PM ET
$8.56
-$0.14 (-1.61%)
After-hours:
Nov 16, 2026, 7:33 PM ET
Teladoc Health Company Profile
Company profile explainedCompany Profile
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Key Executives
| Name | Position |
|---|---|
| Charles Divita | Chief Executive Officer & Director |
| Teri Condon | Chief of Staff to the CEO |
| Adam Christian Vandervoort | Chief Legal Officer & Secretary |
| Dave Ross | Chief Technology Officer |
| Michael Fitzgerald Grasher | Chief Financial Officer |
| Carlos Nueno | President of International |
| Fernando Madeira | President of BetterHelp |
| George Byron Brooks | Co-Founder |
| Joseph Ronald Catapano Cpa | Senior Vice President & Chief Accounting Officer |
| Kelly Bliss | President of U.S. Group Health |
| Laura Whipple | Chief Communications & Brand Officer |
| Michael Minchak | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly Report |
| Oct 28, 2026 | 8-K | Current Report |
| Oct 08, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 05, 2026 | 4 | Filing |
| Sep 25, 2026 | 8-K | Current Report |
| Sep 14, 2026 | 4 | Filing |
| Sep 11, 2026 | 144 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
| Sep 03, 2026 | 4 | Filing |
Teladoc Health
| Country | United States |
| IPO Date | Jun 30, 2015 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 5,124 |
| CEO | Charles Divita |
Contact Details
155 E 44th Street New York,
New York 10017 United States
Stock Details
| Ticker Symbol | TDOC |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001477449 |
| CUSIP Number | 87918A105 |
| ISIN Number | US87918A1051 |
| SIC Code | 8011 |
Recent News
- 4 days ago / businesswire.comTeladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province
- 13 days ago / globenewswire.comTeladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
- 19 days ago / 247wallst.comTeladoc Soars 26% as Revenue and Profit Beat Estimates; Hims & Hers Health and American Well Tick Up
- 19 days ago / benzinga.comTeladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook
- 19 days ago / seekingalpha.comTeladoc Health, Inc. (TDOC) Q3 2026 Earnings Call Transcript
- 19 days ago / marketbeat.comTeladoc Health Q3 Earnings Call Highlights
- 19 days ago / fool.comTeladoc: 3 Key Takeaways for Long-Term Investors
- 19 days ago / zacks.comTeladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- 19 days ago / zacks.comTeladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates
- 19 days ago / globenewswire.comTeladoc Health Reports Third Quarter 2026 Results
Add to Watchlist
Select watchlists to add or remove TDOC